Velsera Technology Paves the Way for Advanced Cancer Diagnostics with FDA Approval of Illumina TruSight™ Oncology Comprehensive IVD
Read more
News
On September 16, 2024 | By The Velsera Clinical and Compliance Team
Blog
On September 12, 2024 | By Liam Scott
A Story of Support: Our Innovation Improves Your Results
Read more
Blog
On August 23, 2024 | By Lea Lenhardt Ackovic
STAARpipeline apps: Enhancing Rare Variant Analysis in Whole-Genome Sequencing Studies
Read more
Blog
On July 23, 2024 | By The Velsera Clinical and Compliance Team
Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2
Read more
Blog
On July 18, 2024 | By Julie Furt
Enhancing the Precision Medicine Journey
Read more
Blog
On July 9, 2024 | By The Velsera Clinical and Compliance Team
Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You
Read more
News
On June 28, 2024 | By The Velsera Clinical and Compliance Team
Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey
Read more
News
On June 27, 2024 | By The Velsera Clinical and Compliance Team
Genetic Sequence Data Analysis & Reporting Accelerated with Velsera’s Release of CGW Plus
Read more
Blog
On June 20, 2024 | By The Velsera Clinical and Compliance Team
Navigating your molecular lab’s test selection and development over the next two years
Read more
News
On June 3, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show
Read more
Blog
On May 21, 2024 | By Bojana Smiljanic
Unravelling Cellular Complexity: Exploring 3D Genome Structure and DNA Methylation with the snM3C Pipeline
Read more
Blog
On May 14, 2024 | By The Velsera Clinical and Compliance Team
Four Years, Five Stages: the FDA’s Final Rule on LDTs
Read more